Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/20/1996 | US5547696 Growth hormone stabilized with valine |
08/20/1996 | US5547683 Method for producing microgranulated particle |
08/20/1996 | US5547682 Reticulendothelial system contrast agent for use in magnetic resonance imaging |
08/20/1996 | US5547681 Dermal patch |
08/20/1996 | US5547680 Sterilizing carboxypolymethylene solution having acidic ph by heating, forming aminocaproic acid by combining it with water, sterilizating by filter sterilization, combining both solutions to form gel, prevents secondary hemorrhage |
08/20/1996 | US5547678 Mixture of kojic acid and sunscreen agent |
08/20/1996 | US5547677 Antimicrobial oil-in-water emulsions |
08/20/1996 | US5547671 Extracts from kudzu plant, ginseng, ginger, citrus fruits, tree barks, thiamine |
08/20/1996 | US5547662 Preparation of a skin surface for a surgical procedure |
08/20/1996 | US5547656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications |
08/20/1996 | CA2090719C In vivo delivery of active factors by co-cultured cell implants |
08/20/1996 | CA2080648C Process for producing a pharmaceutical tablet |
08/20/1996 | CA2019324C Fosinopril tablet formulations |
08/20/1996 | CA1338530C Means for constraining a rumen drug delivery device in a rolled configuration |
08/18/1996 | CA2169810A1 Formulated medicines and processed foods to treat and prevent stomatitis |
08/15/1996 | WO1996024618A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents |
08/15/1996 | WO1996024377A1 Medicament in particle form |
08/15/1996 | WO1996024375A1 New oral pharmaceutical dosage form |
08/15/1996 | WO1996024374A1 Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants |
08/15/1996 | WO1996024370A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
08/15/1996 | WO1996024363A1 Therapeutic methods and preparations using rubidium ions |
08/15/1996 | WO1996024359A1 Novel pharmaceutical formulation |
08/15/1996 | WO1996024355A1 Novel pharmaceutical combination |
08/15/1996 | WO1996024354A1 Novel pharmaceutical composition |
08/15/1996 | WO1996024352A1 Pridinol-containing patch |
08/15/1996 | WO1996024342A1 Concomitant treatment with oral bismuth compounds |
08/15/1996 | WO1996024341A1 Concomitant treatment with bismuth and antibacterials |
08/15/1996 | WO1996024340A1 A method of preparing stable drug nanoparticles |
08/15/1996 | WO1996024339A1 Compositions comprising nanoparticles of nsaid |
08/15/1996 | WO1996024338A1 New pharmaceutical formulation and process |
08/15/1996 | WO1996024337A1 ORAL DOSAGE-FORMS CONTAINING A β-LACTAM ANTIBIOTIC |
08/15/1996 | WO1996024336A1 Nsaid nanoparticles |
08/15/1996 | WO1996024335A1 Sugar base surfactant for nanocrystals |
08/15/1996 | WO1996024334A1 Lipid constructs for cytoplasmic delivery of agents |
08/15/1996 | WO1996024333A1 Lipid constructs for targeting to vascular smooth muscle tissue |
08/15/1996 | WO1996024332A1 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
08/15/1996 | WO1996024331A1 New medical forms with prolonged effect applied in eye medicine and the method for preparation thereof |
08/15/1996 | WO1996024330A1 Method and device for administering analgesics |
08/15/1996 | WO1996024325A1 Improved topical application emulsions |
08/15/1996 | WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
08/15/1996 | WO1996018300A3 Adherent disinfecting compositions and methods relating thereto |
08/15/1996 | WO1996007397A3 Delivery of solid drug compositions |
08/15/1996 | CA2212520A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
08/15/1996 | CA2212165A1 Method and device for administering analgesics |
08/15/1996 | CA2211464A1 Novel pharmaceutical composition |
08/15/1996 | CA2211409A1 Novel pharmaceutical formulation |
08/15/1996 | CA2211263A1 Improved topical application emulsions |
08/15/1996 | CA2210664A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents |
08/15/1996 | CA2207304A1 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
08/15/1996 | CA2206430A1 Sugar base surfactant for nanocrystals |
08/14/1996 | EP0726321A2 Method for production of arachidonic acid |
08/14/1996 | EP0726075A1 Pharmaceutical non-inorganic saline solutions for endonasal administration |
08/14/1996 | EP0726073A2 Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine |
08/14/1996 | EP0725796A1 Growth differentiation factor-10 |
08/14/1996 | EP0725791A1 Recombinant p53 adenovirus methods and compositions |
08/14/1996 | EP0725789A1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition |
08/14/1996 | EP0725664A1 Disposable dosage unit for iontophoresis-facilitated delivery |
08/14/1996 | EP0725648A1 Hepatoselective pharmaceutical actives |
08/14/1996 | EP0725645A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES |
08/14/1996 | EP0725642A1 Stabilized prostaglandin e 1? |
08/14/1996 | EP0725640A1 Use of lobeline for the treatment of nicotine withdrawal |
08/14/1996 | EP0725637A1 Parenteral busulfan for treatment of malignant disease |
08/14/1996 | EP0725634A1 Plaster for the treatment of nail mycoses |
08/14/1996 | EP0725633A1 Detection of h. pylori in the stomach |
08/14/1996 | EP0725632A1 Controlled release osmotic infusion system |
08/14/1996 | EP0725631A1 Novel method for preparing dry pharmaceuticals capable of virtually instantaneous disintegration, and resulting pharmaceuticals |
08/14/1996 | EP0725630A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients |
08/14/1996 | EP0725629A1 Liposomal defensins |
08/14/1996 | EP0725628A1 Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers |
08/14/1996 | EP0725627A1 Orally-administered dosage form for animals, preparation method therefor and uses thereof |
08/14/1996 | EP0725626A1 Gelatin capsule fill able to foam |
08/14/1996 | EP0725625A1 Gelatin capsule fill able to foam |
08/14/1996 | EP0725624A1 Improvements in and relating to carrier particles for use in dry powder inhalers |
08/14/1996 | EP0725570A1 Composition and system for oral administration to animals |
08/14/1996 | EP0646003B1 Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres |
08/14/1996 | EP0615443B1 Immediate-effect flurbiprofen-containing medicament and its use |
08/14/1996 | EP0474714B1 A fructose-based granulated product and a process for the production thereof |
08/14/1996 | EP0471751B1 Antineoplastic solution and method for treating neoplasms |
08/14/1996 | DE3390423C2 Effervescent tablets mfr. |
08/14/1996 | DE19503993A1 Enteral product contg n-3-fatty acid or deriv and medium chain length tri:glyceride |
08/14/1996 | CN1128957A Implantable drug delivery means |
08/14/1996 | CN1128955A Percutaneously absorbable prepn. |
08/14/1996 | CN1128954A Phosphazene polyelectrolytes as immunoadjuvants |
08/14/1996 | CN1128953A Hydrogel microencapsulated vaccines |
08/14/1996 | CN1128950A Method for modulating human sexual response |
08/14/1996 | CN1128948A Pharmaceutical composition for immounomodulating and adjuvant treatment |
08/14/1996 | CN1128947A Soft-shelled gelatin encapsulated particles |
08/14/1996 | CN1128946A Transfusion container, transfusion prepn., and comprehensive vitamin-containing high-calorie transfusion prepn. |
08/14/1996 | CN1128671A Cyclosporin soft capsule composition |
08/14/1996 | CN1128670A Medicine for curing leukorrhea and prepn. method thereof |
08/14/1996 | CN1128668A Natural medicinal health-care products-complex prescription of pearl and snake powder |
08/14/1996 | CN1128667A Thrombus-eliminating pills |
08/14/1996 | CN1128662A Oral liquid for curing cancer and prepn. method thereof |
08/14/1996 | CN1128660A Medicinal ointment for resolving blood stasis |
08/14/1996 | CN1128658A Method for application of copper salicylacetate |
08/14/1996 | CN1128656A Application of anisodamine for prepn. of eye drops for curing pyopia |
08/14/1996 | CN1128655A Injectable liposomal pharmaceutical prepn. |
08/13/1996 | US5545722 Hepatocyte-growth agent |
08/13/1996 | US5545673 Method for reducing risk of infection by sexually transmitted viruses |
08/13/1996 | US5545637 Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts |